Safety Profile of Rosuvastatin

Authors:

Abstract
Background and objective:Rosuvastatin is a lipid-lowering drug, the newest of a class of drugs called HMG-CoA reductase inhibitors, or ‘statins’, launched in the UK in March 2003. Our objective was...

This publication has 21 references indexed in Scilit: